Scientists Share Insights on a New Approach to Treat Peripheral Neuropathies

A major news story from last year’s Peripheral Nerve Society (PNS) Annual Meeting was the promising research results from studies on the disease-modifying potential of SARM1 inhibition therapies. For the 2018 PNS meeting, we interviewed two experts from the Disarm scientific advisory board for their insights about peripheral neuropathies (PN) and how protecting nerve axons with SARM1 therapies could potentially

Continue Reading